BFSG LLC’s Novo Nordisk A/S (B Shares) ADRhedged NVOH Stock Holding History

BFSG LLC’s Portfolio NVOH Stock Details NVOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20	Closed	-$602	–	750
2025 Q3	$602	Buy	+20	New	+$634	﹤0.01%	679

BFSG LLC's NVOH Position: Q4 2025 in Review

BFSG LLC sold out of Novo Nordisk A/S (B Shares) ADRhedged (NVOH) in Q4 2025, closing a stake of 20 shares — an estimated $602 sold.

BFSG LLC first reported a position in NVOH in Q3 2025 and held it in 1 quarter. The position peaked at $602 in Q3 2025. 0 funds tracked by Wall St. Rank hold NVOH as of Q4 2025.

BFSG LLC reported no remaining Novo Nordisk A/S (B Shares) ADRhedged position as of Q4 2025 after selling out during the quarter.
BFSG LLC sold 20 Novo Nordisk A/S (B Shares) ADRhedged shares in Q4 2025, an estimated $602.
BFSG LLC first reported a position in Novo Nordisk A/S (B Shares) ADRhedged in Q3 2025 and held it in 1 quarter.
BFSG LLC's Novo Nordisk A/S (B Shares) ADRhedged position peaked at $602 in Q3 2025.
0 funds tracked by Wall St. Rank held Novo Nordisk A/S (B Shares) ADRhedged as of Q4 2025.

Based on BFSG LLC's 13F filing for Q4 2025, filed 22 Jan 2026.